Aradigm Corp (ARDM):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Aradigm Corp (ARDM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7054
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aradigm Corp (Aradigm) is a specialty pharmaceutical company that develops and commercializes inhalation drugs for the prevention and treatment of severe respiratory diseases. The company’s product pipeline includes Pulmaquin (ARD-3150) and Lipoquin (ARD-3100) for the treatment of non-cystic bronchiectasis (BE) and cystic fibrosis (CF); ARD-1100, liposomal ciprofloxacin for the treatment of inhalation tularemia, anthrax infections, Q fever and pneumonic plague and ARD-1600, for the prevention and treatment of respiratory and other diseases in tobacco smokers through smoking cessation. Its proprietary pulmonary drug delivery platform, AERx, is customized for the delivery of drugs to the target along with liposomal formulations. Aradigm is headquartered in Hayward, California, the US.

Aradigm Corp (ARDM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aradigm Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Aradigm Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Aradigm Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Aradigm Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Aradigm Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Aradigm Corp, Medical Equipment, Deal Details 10
Grifols Enters Into Licensing Agreement With Aradigm 10
Ingeniatrics Enters Into Licensing Agreement With Aradigm For Flow Focusing And Flow Blurring Technology 11
Equity Offering 12
Aradigm Files Registration Statement for Public offering of Shares for up to USD20 Million 12
Acquisition 13
Grifols Completes Acquisition Of 35% Stake In Aradigm For US$26 Million 13
Aradigm Corp – Key Competitors 14
Aradigm Corp – Key Employees 15
Aradigm Corp – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Aug 14, 2018: Aradigm announces second quarter 2018 financial results 17
May 15, 2018: Aradigm Reports First Quarter 2018 Financial Results 18
Mar 23, 2018: Aradigm Reports Fourth Quarter 2017 And Full Year Financial Results 19
Nov 02, 2017: Aradigm Announces Third Quarter 2017 Financial Results 21
Aug 10, 2017: Aradigm Announces Second Quarter 2017 Financial Results 22
May 15, 2017: Aradigm Announces First Quarter 2017 Financial Results 23
Mar 28, 2017: Aradigm Announces Fourth Quarter 2016 and Full Year Financial Results 24
Corporate Communications 25
Jul 06, 2018: Aradigm Names Dr. Theresa Matkovits As Board Director 25
Feb 09, 2018: Aradigm Announces Personnel Changes 26
Legal and Regulatory 27
Oct 10, 2017: Aradigm Regains Compliance with NASDAQ Listing Requirements 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Aradigm Corp, Medical Equipment, Key Facts, 2017 2
Aradigm Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Aradigm Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Aradigm Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Aradigm Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Aradigm Corp, Deals By Market, 2012 to YTD 2018 8
Aradigm Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Grifols Enters Into Licensing Agreement With Aradigm 10
Ingeniatrics Enters Into Licensing Agreement With Aradigm For Flow Focusing And Flow Blurring Technology 11
Aradigm Files Registration Statement for Public offering of Shares for up to USD20 Million 12
Grifols Completes Acquisition Of 35% Stake In Aradigm For US$26 Million 13
Aradigm Corp, Key Competitors 14
Aradigm Corp, Key Employees 15
Aradigm Corp, Subsidiaries 16

List of Figures
Aradigm Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Aradigm Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Aradigm Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Aradigm Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Aradigm Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Aradigm Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Aradigm Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Aradigm Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Aradigm Corp (ARDM):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Jungheinrich AG:戦略・SWOT・企業財務分析
    Jungheinrich AG - Strategy, SWOT and Corporate Finance Report Summary Jungheinrich AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Yuanta Financial Holding Co., Ltd.:企業の戦略・SWOT・財務情報
    Yuanta Financial Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Yuanta Financial Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Mediaset SpA (MS):企業の財務・戦略的SWOT分析
    Mediaset SpA (MS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Leica Microsystems GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Leica Microsystems GmbH (Leica), a subsidiary of Danaher Corp is a medical device company that manufactures microstructures. The company manufactures, and markets microscopes and scientific instruments. Its products include light microscopes, confocal microscopes, stereo microscopes and macr …
  • Bechtel Corporation:企業の戦略的SWOT分析
    Bechtel Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • University Health Network:製薬・医療:M&Aディール及び事業提携情報
    Summary University Health Network (UHN) is a health care institution that provides patient care, research and educational services, and patient support services. It offers health care services such as palliative care, pharmacy and telehealth. UHN also provides specialized program services, accessibi …
  • APA Group:企業のM&A・事業提携・投資動向
    APA Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's APA Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • CLP Holdings Ltd (00002):電力:M&Aディール及び事業提携情報
    Summary CLP Holdings Ltd (CLP) is an investor and operator in the energy sector of Asia Pacific region. The company invests in power generation, transmission and distribution, and electricity and gas retail activities. Its portfolio includes equity generating and purchase capacities. CLP’s generatio …
  • Bank of Kaohsiung, Ltd.:企業の戦略・SWOT・財務情報
    Bank of Kaohsiung, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank of Kaohsiung, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Samsung Life Insurance Co Ltd:企業の戦略・SWOT・財務情報
    Samsung Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Samsung Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • The Nassau Companies of New York:企業の戦略的SWOT分析
    The Nassau Companies of New York - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • UCB Inc-製薬・医療分野:企業M&A・提携分析
    Summary UCB Inc (UCB), a subsidiary of UCB SA is a healthcare solutions provider that offers therapeutics. The company develops products with an emphasis on central nervous system and immunology therapeutic domains. Its products include cimzia, vimpat, keppra XR, neupro, tussionex pennkinetic, metad …
  • Eli Lilly and Company (India) Pvt Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Eli Lilly and Company (India) Pvt Ltd (Eli Lilly), a subsidiary of Eli Lilly and Company is a drug company that manufactures medicines. The company offers pharmaceutical products for the therapeutic areas such as diabetes, cancer, osteoporosis, cardiovascular disorders and growth-hormone def …
  • Citius Pharmaceuticals Inc (CTXR):企業の財務・戦略的SWOT分析
    Summary Citius Pharmaceuticals Inc (Citius), formerly Trail One Inc is a specialty pharmaceutical company that focuses on the development and commercialization of anti-infective products in adjunct cancer care, and critical care drug products. The company’s proprietary product candidates include Min …
  • FuelCell Energy Inc (FCEL)-エネルギー分野:企業M&A・提携分析
    Summary FuelCell Energy, Inc. (FuelCell Energy) is an integrated fuel cell company that designs, manufactures, installs, operates, and services stationary fuel cell power plants for distributed power generation. It offers proprietary fuel cell products based on Direct FuelCell (DFC) carbonate fuel c …
  • Assore Limited:企業の戦略・SWOT・財務情報
    Assore Limited - Strategy, SWOT and Corporate Finance Report Summary Assore Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Cinkarna Celje d.d. Celje (CICG):企業の財務・戦略的SWOT分析
    Cinkarna Celje d.d. Celje (CICG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Microsoft Corporation (MSFT)-医療機器分野:企業M&A・提携分析
    Summary Microsoft Corporation (Microsoft) is a technology-based company that develops, licenses, and supports software products, services, and devices. The company offers a comprehensive range of operating systems, cross-device productivity applications, server applications, business solution applic …
  • Aurora Spine Corp (ASG):企業の製品パイプライン分析2018
    Summary Aurora Spine Corp (Aurora) is a medical equipment provider that offers surgical tools. The company offers novel solutions in the spinal implant market through a range of minimally invasive, and regenerative spinal implant technologies. It develops and distributes spinal implant products whic …
  • Qdoba Restaurant Corporation:企業の戦略・SWOT・財務情報
    Qdoba Restaurant Corporation - Strategy, SWOT and Corporate Finance Report Summary Qdoba Restaurant Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆